Clinical effects of debulking surgery combined with neoadjuvant chemotherapy in treating ovarian cancer and its influence on tumor markers and immune function
The combination of tumor cell reduction surgery and neoadjuvant chemotherapy for ovarian cancer can significantly shorten surgical and hospitalization time, inhibit tumor marker expression, improve patient immune function and quality of life.
Authors
- Weiwei Wang (ORCID: https://orcid.org/0000-0002-0215-9467)
- Chunmei Yan (ORCID: https://orcid.org/0000-0003-4522-8319)
- Li Zhu (ORCID: https://orcid.org/0000-0002-8561-1729)
- Shengchao Wang (ORCID: https://orcid.org/0000-0002-3504-747X)
- Huijuan Yan
Institutions
- Xian Central Hospital (CN)
- 117th Hospital of People's Liberation Army (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2024-11-20
- DOI
- https://doi.org/10.12669/pjms.40.11.9337
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54